Screener
Rhythm Pharmaceuticals, Inc. RYTM EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s EPS (basic)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported EPS (basic) of -$0.83 in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s EPS (basic) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s EPS (basic) decreased by 2.5% year-over-year, from -$0.81 to -$0.83.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s EPS (basic) has grown at a 23.4% compound annual growth rate (CAGR), from -$1.34 to -$3.11.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude